1072952-41-0

Usage

Uses

Used in Pharmaceutical Industry:
2-Benzyloxypyridin-3-ylboronic acid is used as a building block for the synthesis of complex organic molecules, particularly in the development of new pharmaceuticals. Its reactivity in forming carbon-carbon and carbon-heteroatom bonds makes it an essential component in the creation of novel drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Benzyloxypyridin-3-ylboronic acid is utilized as a key intermediate in the synthesis of various agrochemicals. Its role in creating stable and effective compounds contributes to the development of pesticides, herbicides, and other crop protection agents that enhance agricultural productivity and crop quality.
Used in Organic Synthesis:
2-Benzyloxypyridin-3-ylboronic acid is employed as a versatile reagent in organic synthesis for its ability to participate in a range of chemical reactions. This includes the formation of carbon-carbon bonds, which are crucial for constructing the backbones of complex organic molecules, and carbon-heteroatom bonds, which are essential for introducing functional groups that confer specific properties to the synthesized compounds.
Used in Research and Development:
In academic and industrial research settings, 2-Benzyloxypyridin-3-ylboronic acid is used as a tool for exploring new chemical reactions and mechanisms. Its unique structure and reactivity provide opportunities for chemists to investigate novel synthetic pathways and develop innovative strategies for the synthesis of complex organic molecules.

InChI:InChI=1/C12H12BNO3/c15-13(16)11-7-4-8-14-12(11)17-9-10-5-2-1-3-6-10/h1-8,15-16H,9H2

Upstream product

• 52200-49-4 3-bromo-2-(phenylmethoxy)pyridine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1206773-16-1 N-(4-{2-[3-tert-butyl-6-hydroxy-2-methoxy-5-(2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-ethyl}-phenyl)-methanesulfonamide 
• 1224634-82-5 1-[2-(2-benzyloxy-pyridin-3-yl)-4-tert-butyl-5-methoxy-benzyl]-3-methyl-1,3-dihydro-benzoimidazol-2-one 
• 1224634-84-7 (R)-1-[2-(2-benzyloxy-pyridin-3-yl)-4-tert-butyl-5-methoxy-benzyl]-5-oxo-pyrrolidine-2-carboxylic acid ethyl ester 
• 1206774-90-4 2-benzyloxy-3-(3-bromo-5-tert-butyl-phenyl)-pyridine 
• 1206774-29-9 5-(2-benzyloxy-3-pyridyl)-3-tert-butyl-2-methoxybenzaldehyde 
• 1309857-66-6 C₃₃H₃₄N₂O₅S 
• 1256488-81-9 methyl 2-[2-[5-(2-benzyloxy-3-pyridyl)-3-tert-butyl-2-methoxyphenyl]ethynyl]-5-[bis(methylsulfonyl)amino]benzoate 
• 1256489-09-4 C₃₃H₃₆N₂O₇S 
• 1256489-08-3 C₃₃H₃₄N₂O₇S 
• 1256489-07-2 C₃₂H₃₄N₄O₅S 
• 1256488-83-1 N-[3-[3-tert-butyl-2-methoxy-5-(2-oxo-1H-pyridin-3-yl)phenyl]-1-oxo-isochromen-7-yl]-N-methylsulfonylmethanesulfonamide 
• 1256488-98-8 C₂₆H₃₂N₂O₆S 
• 1256489-18-5 C₃₃H₃₈N₂O₆S 
• 1256489-02-7 C₃₂H₃₀N₂O₃ 

Relevant academic research and scientific papers

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds having the formula I wherein R1, R2, R3, R4, R5a, R5b, R5c and R6 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds having the formula I wherein wherein R1, R2, R3b, R4a, R4b, R4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds having the formula A-R wherein A is a hetereoaryl and R is Ia, Ib or Ic and wherein A, R, R1, R2a, R2b, R2c, R3a, R3b, R4, R5, R6, Ra, Rb, Rc, Rd, X, X1, X2 and n are as are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication. R is

Heterocyclic antiviral compounds

Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.